CFTR and cystic fibrosis: The major concerns to broad implementation of antifungal therapy in early CF are the rising incidence of azole resistance in environmental and clinical Aspergillus [4,10] and the contra-indication of some antifungals with CFTR (cystic fibrosis transmembrane conductance regulator) modulators [18], now an essential part of CF therapy [19].